A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Circle 1500 Bookmark and Share

Circle 1500 benefits the Women’s Cancers Program at City of Hope

Our annual membership dues supports innovative research in search of solutions to breast and gynecologic cancers. Each year we vote to fund one of several promising research projects.

How can I help?
  • Join Circle 1500
  • Attend quarterly meetings and events
  • Vote on proposed projects
  • Encourage friends to join
 
Membership Dues
Annual membership is $500 (fully tax-deductible) and includes:

  • Four meetings each year
  • Annual celebration highlighting
  • Circle 1500-funded research
  • Opportunities to learn about important women’s health issues

Join the Founder’s Circle for $1,500 (fully tax-deductible), which also includes:
 
  • Invitation-only opportunities to interact with Women’s Cancers Program physicians and researchers
     
 
 

For more information or to join, contact Janet Morgan at 626-218-6250 or jmorgan@coh.org.
 

 
About City of Hope's Women's Cancers Program
City of Hope has a history of innovation — including the technology behind Herceptin, a breakthrough drug for breast cancer.
 
Today, the Women’s Cancers Program at City of Hope brings together experts across disciplines in dynamic collaborations. And special on-site drug manufacturing facilities enable City of Hope to translate discovery into treatment faster and more efficiently.
 
Some exciting areas of research in the Women’s Cancers Program:
  • Seeking new treatments that defeat disease with fewer and milder side effects
  • Developing medicines that target women’s cancers precisely
  • Studying superfoods like mushroom and blueberries as ways to prevent or treat women’s cancers
  • Examining which choices women can make to stop cancer before it ever starts
 

Photos

 
Circle 1500's January 2013 Breakfast Meeting: Sexuality After Cancer:
“Often a problem; seldom discussed”
 
An information meeting for Circle 1500 was held at City of Hope on September 19, 2013.  Guests and members met the leadership of the Women’s Cancers Program faculty, heard research updates from the Women’s Cancers Program, and had the opportunity to share their experiences with cancer.  Every woman knows someone who has dealt with breast or gynecologic cancer, and treatment and research advances at City of Hope provide promise for the future.  We welcome you to join our group and help to make a difference.
 
 
 

Circle 1500

Circle 1500 benefits the Women’s Cancers Program at City of Hope

Our annual membership dues supports innovative research in search of solutions to breast and gynecologic cancers. Each year we vote to fund one of several promising research projects.

How can I help?
  • Join Circle 1500
  • Attend quarterly meetings and events
  • Vote on proposed projects
  • Encourage friends to join
 
Membership Dues
Annual membership is $500 (fully tax-deductible) and includes:

  • Four meetings each year
  • Annual celebration highlighting
  • Circle 1500-funded research
  • Opportunities to learn about important women’s health issues

Join the Founder’s Circle for $1,500 (fully tax-deductible), which also includes:
 
  • Invitation-only opportunities to interact with Women’s Cancers Program physicians and researchers
     
 
 

For more information or to join, contact Janet Morgan at 626-218-6250 or jmorgan@coh.org.
 

 
About City of Hope's Women's Cancers Program
City of Hope has a history of innovation — including the technology behind Herceptin, a breakthrough drug for breast cancer.
 
Today, the Women’s Cancers Program at City of Hope brings together experts across disciplines in dynamic collaborations. And special on-site drug manufacturing facilities enable City of Hope to translate discovery into treatment faster and more efficiently.
 
Some exciting areas of research in the Women’s Cancers Program:
  • Seeking new treatments that defeat disease with fewer and milder side effects
  • Developing medicines that target women’s cancers precisely
  • Studying superfoods like mushroom and blueberries as ways to prevent or treat women’s cancers
  • Examining which choices women can make to stop cancer before it ever starts
 

Photos

Photos

 
Circle 1500's January 2013 Breakfast Meeting: Sexuality After Cancer:
“Often a problem; seldom discussed”
 
An information meeting for Circle 1500 was held at City of Hope on September 19, 2013.  Guests and members met the leadership of the Women’s Cancers Program faculty, heard research updates from the Women’s Cancers Program, and had the opportunity to share their experiences with cancer.  Every woman knows someone who has dealt with breast or gynecologic cancer, and treatment and research advances at City of Hope provide promise for the future.  We welcome you to join our group and help to make a difference.
 
 
 
Events
 
Please join us

Thursday, July 16, 2015
6:00 P.M. to 8:00 P.M.
Dinner Meeting

The Home of Vicki Schwartz
(address with R.S.V.P.)
 
Cancer Genomics: Unlocking Cures and Cancer Prevention
Jeffrey Weitzel, M.D.
Director, Clinical Cancer Genetics
 
Prospective members are welcome.

R.S.V.P. to Janet Morgan at 626-218-6250
or jmorgan@coh.org
 

 
 
City of Hope has earned the highest overall rating of four stars for fiscal responsibility from Charity Navigator, America's premier independent charity watchdog group, for the fifth straight year.
Subscribe to news by email
Subscribe to news and updates from City of Hope to get the latest on our research, treatment and other news you can use.  View our privacy policy.
 
 
 
 


NEWS & UPDATES
  • Non-Hodgkin lymphoma facts: Non-Hodgkin lymphoma is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Lymphocytes are in the lymph nodes and other lymphoid tissues (such as the spleen and bone marrow). Non-Hodgkin lymphoma is one of the most common cancers in the U.S....
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...
  • Women diagnosed with breast cancer quickly learn their tumor’s type, meaning the characteristics that fuel its growth. That label guides the treatment of their disease, as well as their prognosis when it comes to treatment effectiveness. Sometimes, however, doctors can’t accurately predict treatment effectivene...
  • In years past, Bladder Cancer Awareness Month has been a sobering reminder of a disease with few treatment options. For patients with metastatic disease (disease that has spread from the bladder to distant organs), average survival is typically just over one year. Fortunately, things are changing. Academic inst...
  • Tina Wang was diagnosed with Stage 4 diffuse large b cell lymphoma at age 22. She first sought treatment at her local hospital, undergoing two cycles of treatment. When the treatment failed to eradicate her cancer, she came to City of Hope. Here, Wang underwent an autologous stem cell transplant and participate...